Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mitochondrial dynamics are crucial for cellular health; dysregulation negatively impacts mitochondria.
• Inhibition of mitochondrial fission protein DRP1 shows therapeutic potential in neurodegenerative models.
• DRP1 expression in Parkinson's disease (PD) brains remains largely uninvestigated.

Purpose of the Study:

• To investigate the expression of DRP1 and other mitochondrial fission/fusion mediators in Parkinson's disease.
• To determine if DRP1 upregulation is present in both human PD brains and relevant animal models.

Main Methods:

• Quantification of DNM1L gene and DRP1 protein levels in human PD brain samples.
• Immunostaining to assess DRP1 expression in specific neuronal and glial cell types.
• Time-course analysis of DRP1 expression and phosphorylation in a mouse model overexpressing SNCA.

Main Results:

• Significant increases in DNM1L and DRP1 levels were observed in Parkinson's patients.
• DRP1 expression was elevated in dopamine neurons, astrocytes, and microglia in PD brains.
• Upregulation and increased phosphorylation of DRP1 were detected in the brains of SNCA transgenic mice.

Conclusions:

• This study demonstrates DRP1 upregulation and altered mitochondrial dynamics in both human and mouse PD brains.
• Findings suggest a pro-fission phenotype contributing to PD pathogenesis.
• Blocking mitochondrial fission or promoting fusion emerges as a potential therapeutic strategy for Parkinson's disease.